Eli Lilly

Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Fierce Pharma
Wed, 07/7/21 - 10:29 pm
Eli Lilly
pharma marketing
Olympics
Trulicity
Emgality
Verzenio
Big pharma leads the way in stock market resurgence
EP Vantage
Wed, 07/7/21 - 10:49 am
Big Pharma
pharma stocks
Acadia Pharmaceuticals
AstraZeneca
Biogen
Eli Lilly
GSK
Merck
Moderna Therapeutics
Novartis
Sanofi
Provention Bio
Lilly makes equity investment in saRNA tech company MiNA Therapeutics
Biopharma Reporter
Tue, 07/6/21 - 10:54 am
Eli Lilly
MiNA Therapeutics
M&A
saRNA
Eli Lilly, Boehringer Ingelheim tout pivotal heart failure win for Jardiance, potentially setting up a Novartis showdown
Endpoints
Tue, 07/6/21 - 10:52 am
Eli Lilly
Boehringer Ingelheim
heart failure
clinical trials
Jardiance
Amid rush of scandals, Eli Lilly settles sex discrimination, harassment suit with former lobbyist
Fierce Pharma
Thu, 07/1/21 - 10:41 am
Eli Lilly
sexual harassment
gender discrimination
Eli Lilly will consider lower insulin prices, CEO says
Beckers Hospital Review
Wed, 06/30/21 - 12:19 am
Eli Lilly
David Ricks
Pharma CEOs
insulin
drug prices
diabetes
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
Fierce Pharma
Sun, 06/27/21 - 10:57 pm
Novo Nordisk
Ozempic
Eli Lilly
Rybelsus
Trulicity
diabetes
type 2 diabetes
US pauses use of Eli Lilly's Covid-19 treatment nationwide due to variants
Endpoints
Fri, 06/25/21 - 12:15 pm
Eli Lilly
COVID-19
COVID-19 variants
monoclonal antibodies
Reversing course, Lilly to seek fast approval for experimental Alzheimer's drug
BioPharma Dive
Thu, 06/24/21 - 12:38 pm
Eli Lilly
donanemab
FDA
Alzheimer's disease
Farxiga faces first heart failure rival as EU OKs Boehringer/Lilly’s Jardiance
Pharmaforum
Wed, 06/23/21 - 10:59 am
AstraZeneca
Farxiga
heart failure
Boehringer Ingelheim
Eli Lilly
Jardiance
Lilly helps Circle round up $66M for intractable target R&D
Fierce Biotech
Thu, 06/17/21 - 10:56 am
Circle Pharma
cyclin
Eli Lilly
R&D
funding
Boehringer, Lilly and Takeda join matchmaker PharmStars' digital health accelerator
Fierce Pharma
Wed, 06/16/21 - 11:50 am
PharmStars
digital health
accelerators
Takeda
Eli Lilly
Boehringer Ingelheim
Terns Pharmaceuticals touts safety data from an ex-Eli Lilly candidate in the hunt for NASH treatment
Endpoints
Tue, 06/15/21 - 11:35 pm
Terns Pharmceuticals
Eli Lilly
FXR agonists
NASH
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study
Fierce Pharma
Tue, 06/15/21 - 10:35 am
Eli Lilly
Emgality
migraines
Biohaven
Nurtec
Eli Lilly, Roche's Alzheimer's prospects, including flops, boosted in light of FDA's Aduhelm approval: analysts
Fierce Biotech
Fri, 06/11/21 - 12:10 pm
Eli Lilly
Roche
Biogen
Alzheimer's disease
FDA
beta-amyloid plaque
Lilly's internal probe into Branchburg, New Jersey, plant found company didn't mislead FDA, but DOJ investigation remains: report
Fierce Pharma
Fri, 06/11/21 - 10:54 am
Eli Lilly
DOJ
drug manufacturing
FDA
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
drug development
MannKind
Thirona Bio
pulmonary fibrosis
Oyster Point Pharma
Adaptive Phage Therapeutics
ophthalmic
Takeda
Codexis
ALX Oncology
Eli Lilly
clinical trials
BeiGene
Shoreline Biosciences
oncology
#ASCO21: Eli Lilly-partnered Merus reveals new data for NRG1 fusion cancers including pancreatic and NSCLC
Endpoints
Sat, 06/5/21 - 02:17 pm
ASCO 2021
Merus
Eli Lilly
clinical trials
solid tumors
Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial
Yahoo/Benzinga
Thu, 06/3/21 - 11:03 am
Eli Lilly
clinical trials
rheumatoid arthritis
olumiant
Eli Lilly Collab Scores IND Approval for Dicerna's RNAi Cardiometabolic Drug
BioSpace
Thu, 05/27/21 - 11:09 am
Dicerna
Eli Lilly
LY3819469
clinical trials
RNAi
cardiometabolic diseases

Pages